Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000180281 | SCV000232684 | benign | not specified | 2014-08-06 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000180281 | SCV000513219 | benign | not specified | 2015-04-09 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000461891 | SCV000554500 | benign | Brugada syndrome 8 | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000620288 | SCV000735109 | benign | Cardiovascular phenotype | 2015-08-04 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV003736623 | SCV004564152 | benign | not provided | 2022-12-21 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000180281 | SCV005077327 | benign | not specified | 2024-04-08 | criteria provided, single submitter | clinical testing |